Insider · CIK 0001107092
Thomas Reddin
Files at DLX (DELUXE CORP), SKT (TANGER INC.), ABG (ASBURY AUTOMOTIVE GROUP INC). First filing May 13, 2025, latest May 13, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
SKT: TANGER INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 33Weak | SKTsell TANGER INC. | $226k 7,000 shares | -15% | +8% from low-13% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 22, 2025 | DLX DELUXE CORP | GGift Common Stock | -250 | $0.00 | $0 | 24,307 | Dec 23, 2025 |
| Dec 22, 2025 | DLX DELUXE CORP | GGift Common Stock | -250 | $0.00 | $0 | 24,057 | Dec 23, 2025 |
| Dec 12, 2025 | DLX DELUXE CORP | GGift Common Stock | -250 | $0.00 | $0 | 25,057 | Dec 16, 2025 |
| Dec 12, 2025 | DLX DELUXE CORP | GGift Common Stock | -250 | $0.00 | $0 | 24,807 | Dec 16, 2025 |
| Dec 12, 2025 | DLX DELUXE CORP | GGift Common Stock | -250 | $0.00 | $0 | 24,557 | Dec 16, 2025 |
| May 12, 2025 | SKT TANGER INC. | SOpen-market sale Common Stock | -7,000 | $32.25 | $226k | 39,602 | May 13, 2025 |
| Apr 24, 2025 | DLX DELUXE CORP | AGrant or award Restricted Stock Unitderivative | +10,349 | $0.00 | $0 | 10,349 | Apr 25, 2025 |
| Feb 19, 2025 | ABG ASBURY AUTOMOTIVE GROUP INC | AGrant or award Common Stock | +713 | $0.00 | $0 | 11,115 | Feb 21, 2025 |
| Feb 19, 2025 | ABG ASBURY AUTOMOTIVE GROUP INC | FTax withholding Common Stock | -250 | $294.50 | $74k | 10,865 | Feb 21, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.